RINVOQ EXTENDED-RELEASE TABLET 15MG
Product details
Registration number: SIN15959P
Classification: Prescription Only
Active ingredients: Upadacitinib Hemihydrate eqv Upadacitinib
Strength: 15mg
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Registrant: ABBVIE PTE. LTD.
ATC code: L04AA44
HSA approval date: 16 June 2020
Manufacturer(s):
- AbbVie Ireland NL B.V.
- AbbVie S.r.l. (Primary and Secondary Packager)
Manufacturing country/countries: ITALY; IRELAND
What are the HSA registration number and classification for RINVOQ EXTENDED-RELEASE TABLET 15MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15959P
Classification: Prescription Only
What active ingredients and strength are recorded for RINVOQ EXTENDED-RELEASE TABLET 15MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Upadacitinib Hemihydrate eqv Upadacitinib
Strength: 15mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RINVOQ EXTENDED-RELEASE TABLET 15MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for RINVOQ EXTENDED-RELEASE TABLET 15MG?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBVIE PTE. LTD.
Which manufacturers and countries are listed for RINVOQ EXTENDED-RELEASE TABLET 15MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- AbbVie Ireland NL B.V.
- AbbVie S.r.l. (Primary and Secondary Packager)
Manufacturing country/countries: ITALY; IRELAND
Where can I look up RINVOQ EXTENDED-RELEASE TABLET 15MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15959P or the exact product name RINVOQ EXTENDED-RELEASE TABLET 15MG. The general register link does not preselect this product.
What are the source dates for this RINVOQ EXTENDED-RELEASE TABLET 15MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RINVOQ EXTENDED-RELEASE TABLET 15MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15959P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)